Abstract
Aims:
To determine the interpersonal and structural factors associated with receptive syringe sharing (RSS) among female sex workers who inject drugs (FSW-IDU), a group at high risk of HIV/HCV acquisition.
Design:
SAPPHIRE study, a prospective cohort study.
Setting:
Baltimore, Maryland, USA.
Participants:
180 FSW-IDU. Mean age was 33 years, 77.1% were white, and 62.9% in a relationship/married.
Measurements:
Surveys were conducted between April 2016 and February 2018. The main outcome was recent RSS (past 3 months). In addition to socio-demographic characteristics and drug use behaviors, we assessed factors at the interpersonal-level, including injection practices, intimate partner and client drug use, and exposure to violence. Structural-level factors included methods of syringe access.
Findings:
Nearly all FSW-IDU used heroin (97.1%) or crack cocaine (89.7%). Recent RSS was reported by 18.3%. Syringes were accessed from needle exchange programs (64.6%), pharmacies (29.7%), street sellers (30.3%), or personal networks (29.1%). Some FSW-IDU had clients or intimate partners who injected drugs (26.3% and 26.9% respectively). Longitudinal factors independently associated with RSS in the multilevel mixed-effects model were recent client violence (adjusted odds ratio[aOR]=2.17, 95% CI:1.09–4.33), having an intimate partner who injected drugs (aOR=2.18, 95% CI:0.98–4.85), being injected by others (aOR=4.95, 95% CI:2.42–10.10), and obtaining syringes from a street seller (aOR=1.88, 95% CI:0.94–3.78) or from a member of their personal network (aOR=4.43, 95% CI:2.21–8.90).
Conclusions:
Client violence, intimate partner injection drug use, being injected by others, and obtaining syringes from personal connections, appear to increase parenteral HIV/HCV risk among female sex workers who inject drugs.
Keywords: Women, HIV risk, injection drug use, substance use
Introduction
Female sex workers (FSW) and women who inject drugs (WWID) are distinct yet overlapping populations at high risk of HIV and hepatitis C virus (HCV) acquisition globally. The degree of overlap between these populations vary widely from 18% to 61% in the U.S., Canada, Mexico and Russia (1–4). Among FSW and WWID worldwide, HIV prevalence is high, at 12% among FSW (5) and 18% among WWID (6). In Europe, injection drug use (IDU) is the primary driver of HIV risk among FSW (7). HCV has a higher viral infectivity compared to HIV during parenteral transmission and more likely to survive in injection paraphernalia (8, 9); 52% of all people who inject drugs (PWID) globally are HCV-antibody seropositive (6), and small gender differences in HCV seroprevalence have been observed in some settings (10, 11). Receptive syringe sharing (RSS), involving reuse of a syringe used by someone else, is a key HIV/HCV risk factor among PWID, and the prevalence of RSS has been documented to be higher among WWID in the U.S. (12, 13).
Globally, there is growing recognition that contextual factors, including social environments and socioeconomic inequities, may shape individual-level susceptibility to disease (14–16). However, literature exploring interpersonal and structural determinants of parenteral HIV/HCV risk among FSW who engage in IDU (FSW-IDU) is limited (17). Connell’s Theory of Gender and Power (18, 19) informs our understanding of the gendered dynamics surrounding HIV/HCV risk behaviors. The theory posits that women’s agency in protecting their health is influenced by gendered inequities in labor, power, and emotional relations (“cathexis”) manifested in the personal relationships between women and men; these gendered dynamics can shape HIV/HCV risk among FSW/WWID (20–23). For instance, the sexual division of labor within these dyads can shape women’s unequal economic resources leading to limited money for drugs, leading to over-reliance on partners or engagement in sex work. Power imbalances can constrain women’s control within relationships and promote client or partner use of physical or financial threats to demand sex. Cathexis can promote the enforcement of strict gender roles, including reliance on injection by male partners. Women’s exposure to police and the criminal justice system reflects Connell’s social structures at the institutional level: in some settings, police abuse their power over FSW to coerce sexual favors (24, 25). At the macro level, the criminalization of sex work and drug use disproportionately affects women in the U.S. (26).
Syringe sharing and access to syringes among WWID represent important manifestations of all three of Cornell’s structures, with key implications for women’s HIV/HCV risk. At the interpersonal-level, WWID report higher syringe sharing than their male counterparts and are more likely to share syringes with interpersonal connections including intimate partners (IP) and friends (27–29). Male IP-IDU and exposure to intimate partner violence (IPV) regardless of the partner’s IDU are associated with RSS among WWID, revealing a gendered power imbalance constraining the ability to engage in safer IDU (30–32). Institutional and interpersonal factors that exert power over women’s access to syringe services programs (SSPs) include childcare needs, neighborhood safety, and trauma history (26), which is particularly concerning given the effectiveness of SSPs in preventing blood-borne infections and other health morbidities (33, 34).
The few studies exploring the unique vulnerabilities of FSW-IDU show higher prevalence of HIV prevalence, unrecognized HIV infection, sexual risk, and RSS (1, 3, 35–39). To build on this literature, the current longitudinal study examines the relative contribution of clients and IPs, and structural factors in shaping HIV risk through RSS among FSW-IDU in an urban U.S. setting. We hypothesized that interpersonal (e.g., gender-based violence; GBV) and structural factors (e.g., relying on IPs for syringes) would elevate HIV/HCV risk.
Methods
The Sex workers And Police Promoting Health In Risky Environments (SAPPHIRE) study is a mixed methods study with a qualitative police ethnography phase and an observational prospective cohort of 250 cisgender FSW in Baltimore, Maryland (40). The study examined the role of the police on the HIV risk environment of street-based FSW. Recruitment and data collection occurred between April 2016 and February 2018 and there were five study visits (baseline, 3-/6-/9-/12-month follow-up). Methods have been published previously (40–42). Briefly, women were recruited through targeted sampling at street-based locations with sex work activity. Detailed description of the methodology have been published elsewhere (41). These locations (“recruitment zones”) were identified through geospatial analyses of secondary data sources (e.g., arrest data, 911 data) and corroborated through ethnographic work with Baltimore Police and interviews with community stakeholders, including former sex workers. The 12 recruitment zones ranged in size (ranging between 2 to 10 blocks) and were geographically diverse. In the current analysis, a median of 24 participants were recruited from each zone (IQR=6–36).
Women were approached on the street and if interested, screened in the study van. Eligibility criteria were: (1) age ≥ 15 years; (2) sold or traded oral, vaginal or anal sex “for money or things like food, drugs or favors”; (3) picked up clients on the street or at public places ≥ 3 times recently (in the past 3 months); and (4) willing to undergo HIV and STI testing. After providing informed consent, participants completed a 50-minute computer-assisted personal interview (CAPI) with a trained interviewer and HIV/STI testing. Participants were permitted to complete any study visit as long as they were within the window period regardless of completion of their prior visit. Participants were compensated with $70 for baseline and 12-month visits, and $45 for 3-, 6- and 9-month visits. Retention rates at 3-, 6-, 9-, and 12-month were 81%, 74%, 76% and 73%, after excluding loss to follow-up due to reasons that prohibited study participation during their follow-up window (e.g., deceased, incarcerated, enrolled in inpatient drug rehabilitation). The study was approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board.
Measures
In addition to determining key socio-demographic characteristics, our surveys captured aspects of FSW’s lives, particularly those influenced by gender and power dynamics including frequency of sex work, being trafficked into sex work, having a pimp or manager, and interactions with sex work clients. Childhood abuse included pressured/forced sexual intercourse, or sexual touching, before the age of 18, and being ‘pushed, grabbed, slapped, had something thrown at you, or were hit so hard you had marks or were injured before the age of 18’. GBV during adulthood was defined as pressured or forced vaginal or anal sex, physical violence, or being threatened or hurt with a weapon but ascertained separately by perpetrator type. We measured FSW interactions with police officers (who are mostly male in this context) including moving to unfamiliar areas to work due to policing, being searched and arrested by police. Engaging in dually illicit activities (drug use and sex work) places FSW at greater risk of police violence due to more frequent police interactions.
Baseline and follow-up surveys also included drug use items based on our previous work (43, 44). The primary outcome (recent RSS; in the past 3 months) was assessed using the first response of the following question: “In the last 3 months, did you use any of the following items that you know have been used by someone else?” Syringes or needles (yes/no). The survey also captured reuse of cookers and cotton. Drug use frequencies were measured at every visit using pre-defined categories, ranging from daily use to 1–3 times a year, and by route of administration, which included the following: heroin (snorted/sniffed/injected), crack (smoked), cocaine (sniffed/snorted/injected), speedball (‘injected heroin and cocaine together’), and non-medical painkillers (‘taken by mouth or sniffed any prescription painkillers that were not prescribed by your doctor such as Percocet, Morphine, Oxycontin, Codeine, Fentanyl but not “over the counter” pills’). Binary variables (used recently; yes/no) were constructed from these items.
The survey also asked questions on FSW’s access to sterile syringes and injection practices, which are also subject to gendered power dynamics, and structural forces. These included interpersonal factors describing interactions with clients and IP, such as IDU, and if respondents were injected by others and by whom. We also measured methods of syringe access (select all that apply: Baltimore City Needle Exchange Program/ Street needle seller/ Pharmacy/ From a sex worker/ From a friend/ From a drug dealer/ Other, specify) and police encounters were also measured at follow-up visits. We assessed proximity to SSPs by obtaining the geospatial street intersection locations provided by the Baltimore City NEP van during the study period (n=16 sites; this was the sole SSP in the city during this period) and overlaying these locations with the mapped recruitment zones created as part of the targeted sampling process (41). A binary variable indicating inclusion of an SSP in a recruitment zone was constructed.
Statistical analysis
The SAPPHIRE cohort consisted of N=250 FSW. Non-IDU (n=66) and observations missing recent RSS (n=2) were excluded from the analysis resulting in n=175 FSW-IDU. We explored the unadjusted baseline associations between the outcome (recent RSS) and the individual, interpersonal and structural covariates that were selected a priori using theory and existing literature; these covariates are listed in Tables 1–3. Significant associations were detected using the Pearson’s χ2 test for binary and categorical covariates, and the Mann-Whitney-U test for continuous covariates. Adjustments for recruitment zone were not applied during this stage.
Table 1:
Baseline Individual-Level Factors Associated with Receptive Syringe Sharing among Female Sex Workers who Inject Drugs (N=175)
RSS, past 3 months | ||||
---|---|---|---|---|
Total | Yes | No | ||
n (col %) | n (col %) | n (col %) | p | |
Total (row %) | 175 (100.0) | 32 (18.3) | 143 (81.7) | |
Individual characteristics | ||||
Age (median, IQR) | 33 (28–39) | 35 (28–40) | 33 (28–38) | 0.754 |
Race/ethnicity | ||||
Non-Hispanic White | 135 (77.1) | 27 (84.4) | 108 (75.5) | |
Non-Hispanic Black | 18 (10.3) | 1 (3.1) | 17 (11.9) | |
Hispanic or Other | 22 (12.6) | 4 (12.5) | 18 (12.6) | 0.33 |
Did not graduate high school | 92 (52.6) | 13 (40.6) | 79 (55.2) | 0.134 |
Relationship status | ||||
Single | 64 (36.6) | 11 (34.4) | 53 (37.1) | |
Married/in a relationship | 110 (62.9) | 21 (65.6) | 89 (62.2) | 0.755 |
Homeless, past 3 months | 119 (68.0) | 23 (71.9) | 96 (67.1) | 0.603 |
Minor (age<18 years) at sex work entry | 41 (23.4) | 11 (34.4) | 30 (21.0) | 0.106 |
Been in sex work ≤ 5 years | 82 (46.9) | 12 (37.5) | 70 (49.0) | 0.241 |
Frequency of sex work, daily | 125 (71.4) | 22 (68.8) | 103 (72.0) | 0.711 |
HIV-positive | 10 (5.8) | 3 (9.4) | 7 (4.9) | 0.329 |
Drug use behaviors, past 3 months | ||||
Heroin | 170 (97.1) | 32 (100.0) | 138 (96.5) | 0.283 |
Crack cocaine | 157 (89.7) | 30 (93.8) | 127 (88.8) | 0.406 |
Powdered cocaine | 30 (17.1) | 3 (9.4) | 27 (18.9) | 0.197 |
Prescription opioid misuse | 47 (26.9) | 8 (25.0) | 39 (27.3) | 0.76 |
Frequency of injection drug use | ||||
≥ Daily | 142 (81.1) | 27 (84.4) | 115 (80.4) | |
< Daily | 33 (18.9) | 5 (15.6) | 28 (19.6) | 0.605 |
Reused cookers | 54 (30.9) | 29 (90.6) | 25 (17.5) | <0.001 |
Reused cotton | 35 (20.0) | 23 (71.9) | 12 (8.4) | <0.001 |
Note: Categorical variables tested using Pearson’s Chi-Squared, continuous variables tested using Mann-Whitney U test
Table 3:
Baseline Structural Factors Associated with of Receptive Syringe Sharing among Female Sex Workers who Inject Drugs (N=175)
RSS, past 3 months | ||||
---|---|---|---|---|
Total | Yes | No | ||
n (col %) | n (col %) | n (col %) | p | |
Total (row %) | 175 (100.0) | 32 (18.3) | 143 (81.7) | |
Syringe access | ||||
Obtained syringes in past 3 months from: | ||||
Needle Exchange / SSP | 113 (64.6) | 22 (68.8) | 91 (63.6) | 0.617 |
Pharmacies | 52 (29.7) | 11 (34.4) | 41 (28.7) | 0.539 |
Street seller | 53 (30.3) | 16 (50.0) | 37 (25.9) | 0.008 |
Personal network (e.g. Intimate partner, friend) | 51 (29.1) | 20 (62.5) | 31 (21.7) | <0.001 |
Recruited at zone containing a SSP | 106 (60.6) | 19 (59.4) | 87 (60.8) | 0.878 |
Police encounters | ||||
Ever | ||||
Moved to a difference neighborhood to work | 54 (30.9) | 9 (28.1) | 45 (31.5) | 0.711 |
Past 12 months | ||||
Moved to an unfamiliar area to work due to policing | ||||
Arrested | 89 (50.9) | 17 (53.1) | 72 (50.3) | 0.777 |
Police sexual or physical violence | 48 (27.4) | 10 (31.3) | 38 (26.6) | 0.592 |
Past 3 months | ||||
Referred you to health/social services | 22 (12.6) | 3 (9.4) | 19 (13.3) | 0.546 |
Asked you to move on from a specific stroll/other public space | 127 (72.6) | 26 (81.3) | 101 (70.6) | 0.132 |
Conducted a search of your person and property | 82 (46.9) | 17 (53.1) | 65 (45.5) | 0.432 |
Confiscated syringes or drug paraphernalia from you | 43 (24.6) | 11 (34.4) | 32 (22.4) | 0.154 |
Confiscated drugs from you | 30 (17.1) | 6 (18.8) | 24 (16.8) | 0.79 |
Note: Categorical variables tested using Pearson’s Chi-Squared, continuous variables tested using Mann-Whitney U test
SSP=Syringe Services Program
FSW-IDU (n=184) completed 654 study visits over the follow-up period; due to IDU cessation and initiation during the study, only visits where recent IDU was reported were considered for multivariate analysis resulting in 443 visits in the dataset. FSW (n=12) who did not report recent IDU at baseline but did at a subsequent visit were included. Bivariate associations between each time-varying covariate listed in Tables 1–3 and the outcome were modeled at this stage using multilevel mixed-effects logistic models, which accounted for intra-person correlations due to repeated measurements and variance clustering by baseline recruitment zone. Associations significant at the p<0.1 level are shown in Table 4. These variables were considered for multivariate modeling, with the exception of cooker/cotton resuse due to the established degree of concomitance between these behaviors and RSS.
Table 4:
The Relationship between, Dyad-level and Structural Factors and Receptive Syringe Sharing among a Longitudinal Cohort of Female Sex Workers who Inject Drugs (N=180 women, N=433 visits), Baltimore, Maryland
OR (95% CI) | p | aOR (95% CI) | p | |
---|---|---|---|---|
Dyad-level, past 3 months | ||||
Ever had a pimp/manager | 3.96 (1.21–12.97) | 0.023 | -- | -- |
Client violence | 3.79 (1.80, 7.94) | <0.001 | 2.17 (1.09, 4.33) | 0.027 |
Intimate partner violence | 2.91 (1.16, 7.26) | 0.022 | -- | -- |
Intimate partner injected drugs | 2.90 (1.39, 6.06) | 0.005 | 2.18 (0.98, 4.85) | 0.056 |
Injected by others | 6.94 (3.46, 13.93) | <0.001 | 4.95 (2.42, 10.10) | <0.001 |
Structural-level, past 3 months | ||||
Obtained syringes from street seller | 2.56 (1.42, 4.59) | 0.002 | 1.88 (0.94, 3.78) | 0.076 |
Obtained syringes from personal network e.g. intimate partner or friend |
3.91 (2.15, 7.11) | <0.001 | 4.43 (2.21, 8.90) | <0.001 |
Note: Multilevel mixed-effects models accounting for intra-person correlations and variance clustering by baseline recruitment zone. All covariates are dichotomous (yes/no), with the reference group being the “no” category. The within-person variance estimate was 1.8 and standard error was 1.6. The within-zone variance estimate and standard error was negligible (approached zero).
Multivariate analysis was conducted using multilevel mixed-effects modelling consisting of a three-level model (visit: level 1, participant: level 2, recruitment zone: level 3) with a Bernoulli distribution, logistic cumulative distribution function and an unstructured covariance structure. We tested a full model (individual, social and structural-level covariates significant at the p<0.1 level) and several alternative models using manual stepwise deletion to narrow down the covariates. Given the high collinearity between the three IP variables (IPV, IP-IDU, and partner injected FSW), models that added one or two of these variables were compared to a model without these three variables. The lowest value of the Akaike information criterion (AIC) was used to select the final model among all models. Complete case analysis was used, resulting in 433 visits among n=180 FSW-IDU.
Results
Baseline prevalence and bivariate associations between recent RSS and individual and drug use factors for FSW-IDU (n=175) are located in Table 1. At baseline, 18.3% reported recent RSS (22.2%, 18.8%, 15.6% and 9.1% during follow-up). Median age was 33, most (77.1%) were Non-Hispanic White, in a relationship/married (62.9%) and recent homeless (68.0%). Half (52.6%) did not graduate high school. Almost half (46.9%) had been in sex work for 5 years or less, a minority had ever had a pimp/manager (12.0%) and most sold sex daily (71.4%). Almost all recently used heroin (97.1%) or crack cocaine (89.7%). Almost all FSW-IDUs were daily IDU (81.1%). Many reused cookers (30.9%) or cotton (20.0%) that had recently been used by someone else. Most who engaged in RSS also shared cookers/cotton (90.6%). A minority of the overall sample did not engage in RSS yet shared cookers/cotton (14.8%).
FSW-IDUs who engaged in RSS had significantly higher proportions of reusing cookers and cottons (both p<0.001), having IP-IDU (p=0.001) and being injected by a friend (p=0.038) or an IP (p<0.001) (Table 1). They also had significantly higher prevalence of client violence (p=0.017) and IPV (p=0.003) (Table 2).
Table 2:
Baseline Dyad-Level Factors Associated with Receptive Syringe Sharing at Baseline among Female Sex Workers who Inject Drugs (N=175)
RSS, past 3 months | ||||
---|---|---|---|---|
Total | Yes | No | ||
n (col %) | n (col %) | n (col %) | p | |
Total (row %) | 175 (100.0) | 32 (18.3) | 143 (81.7) | |
Sex work history | ||||
Ever had a pimp/manager | 21 (12.0) | 5 (15.6) | 16 (11.2) | 0.485 |
Violence | ||||
Childhood sexual or physical violence | 96 (54.9) | 20 (62.5) | 76 (53.1) | 0.523 |
Trafficked into sex work^ | 14 (8.0) | 3 (9.4) | 11 (7.7) | 0.751 |
Client violence, past 3 months | 66 (37.7) | 18 (56.3) | 48 (33.6) | 0.017 |
Intimate partner violence, past 3 months | 29 (16.6) | 11 (34.4) | 18 (12.6) | 0.003 |
Injection risk, past 3 months | ||||
Had IDU client(s) | 46 (26.3) | 11 (34.4) | 35 (24.5) | 0.250 |
Had IDU intimate partner(s) | 47 (26.9) | 16 (50.0) | 31 (21.7) | 0.001 |
Exclusively self-injected | 108 (61.7) | 10 (31.3) | 98 (68.5) | <0.001 |
Injected by someone else | 67 (38.3) | 22 (68.8) | 45 (31.5) | <0.001 |
…Client | 1 (0.2) | 1 (1.3) | 0 (0.0) | |
…Intimate partner | 12 (6.9) | 9 (28.1) | 3 (2.1) | |
…Friend | 41 (23.4) | 12 (37.5) | 29 (20.3) | |
…Acquaintance | 14 (8.0) | 5 (15.6) | 9 (6.3) | |
…Family member | 8 (4.6) | 2 (6.3) | 6 (4.2) |
Defined in this study as being coerced, threatened, pressured, misled, tricked, or physically forced into entering the sex trade.
Note: Categorical variables tested using Pearson’s Chi-Squared, continuous variables tested using Mann-Whitney U test
There were strong associations between having an IP-IDU, being injected by an IP and IPV (χ2 tests, all p<0.001). Syringe access from secondary sources (i.e., street sellers and personal networks, defined as IPs and friends) held separate bivariate associations with decreased SSP access (all p<0.001) (data not shown).
The baseline prevalence of interpersonal and structural factors (i.e., syringe access, police encounters) and their bivariate associations with RSS are located in Table 3. FSW had a mean of 100 male clients in the past 3 months (range 2–840). Of 116 FSW who had an IP, 94.8% were partnered with a male (n=110); 76.4% of this subsample had one male partner and 23.6% had more than one. Approximately a quarter of FSW-IDU had IDU clients/IPs (26.3% and 26.9%, respectively). Some women were recently injected by someone else (38.3%), including friends, acquaintances, IPs and family members. Experiences of violence were common among the sample, including childhood abuse (54.9%), and recent client violence (37.7%) and IPV (16.6%). Only 8.0% reported being trafficked into sex work.
FSW obtained syringes from an SSP (64.6%), pharmacies (29.7%), street sellers (30.3%) and IPs and/or friends (Table 3). Most (60.6%) were recruited from a zone that contained a SSP. Among those who received syringes from street sellers, only n=16/53 (30%) engaged in RSS (Table 3). Similarly, among those who relied on partners, friends, and others only n=20/51 (39%) reported RSS. Only n=8/91 (9%) who did not receive syringes from others (i.e., relied solely on SSP and pharmacies) engaged in RSS (Table 3). Notably, we observed that among FSW-IDU who were injected by someone else, 40% (n=27/67) did not receive syringes from others (i.e., relied solely on SSP and pharmacies). Recent police encounters included being referred to health/social services (12.6%), being asked to move on (72.6%), being searched (46.9%) and having drug paraphernalia (24.6%) or drugs confiscated (17.1%,). About half had been arrested in the past 12 months (50.9%) and experienced some form of police violence (27.4%). Exploratory bivariate analysis demonstrated that obtaining syringes from street sellers (yes vs. no; p=0.008) or their personal network (yes vs. no; p<0.001) were separately associated with engaging in RSS.
Unadjusted analysis incorporating the longitudinal data from N=184 FSW-IDU (N=433 visits; Table 4) showed significant associations between recent RSS and recent client violence (odds ratio[OR]=3.79, 95% CI: 1.80–7.94), recent IPV (OR=2.91, 95% CI: 1.16–7.26), having an IP-IDU (OR=2.90, 95% CI: 1.39–6.06), being injected by others (OR=6.94, 95% CI: 3.46–13.93), obtaining syringes from a street seller (OR=2.56, 95% CI: 1.42–4.59) or from their personal network (OR=3.91, 95% CI: 2.15–7.11).
Factors independently associated with recent RSS in the final adjusted multilevel mixed-effects model were recent client violence (aOR=2.17, 95% CI: 1.09, 4.43), having an IP-IDU (aOR=2.18, 95% CI: 0.98, 4.85), being injected by others (aOR=4.95, 95% CI: 2.42–10.10), obtaining syringes from a street seller (aOR=1.88, 95% CI: 0.94–3.78), or obtaining syringes from their personal network (aOR=4.43, 95% CI: 2.21–8.90).
Discussion
In this study of street-based FSW, IDU and exposure to GBV were extremely prevalent. This is one of the first studies to model and demonstrate strong associations between interpersonal and structural factors on RSS among FSW-IDU, a highly marginalized and vulnerable subpopulation of WWID. The associations supported the theory that gendered dynamics often shape HIV/HCV risk among WWID. At the interpersonal level, recent client violence and injection by others emerged as key correlates of RSS. Structurally, women who accessed syringes through street sellers and personal connections were more likely to engage in RSS. These findings underscore the importance of understanding the potential role of gendered power dynamics between FSW-IDU and key “others” in increasing vulnerability to health risks including HIV/HCV. Addressing the barriers to SSP access and other harm reduction services may also help reduce risk.
These results reveal the primacy of the sexual division of power in shaping the health of FSW-IDU. Two in five were recently exposed to client violence and almost one in six were exposed to IPV, higher than previously reported among FSW-IDU (36, 39). Even after adjustment, client violence doubled the odds of RSS, a novel finding in this population. This adds to existing FSW studies demonstrating associations between client violence and riskier substance use (45–47). Virtually all clients and IPs who perpetrated violence were men, supporting the theory that women’s agency and risk are situated within gendered power dynamics. Exposure to client violence may render these women vulnerable to riskier behaviors by pathways mediated by fear of further abuse, poor mental health or lowered self-esteem (31). Studies have found an association between GBV and engagement in IDU (48), but further research studying the link between violence and riskier injection practices are required among FSW-IDU, a uniquely vulnerable population. Despite the risk of client violence, some women engage in sex work due to pressure from IPs to pay for drugs, often in a context of limited formal and informal economic opportunities (49). Our data highlight the need for pragmatic interventions against GBV among FSW-IDU such as safety training, access to trauma-informed care and justice (21, 50, 51). These interactions occur in a structural context that often fails to provide adequate care, protection and justice to GBV victims, and one where FSW are criminalized and face additional barriers to accessing these services (52).
IP-IDU appeared to play a role in shaping HIV/HCV risk among FSW-IDU, which is consistent with previous research and Connell’s theory (30–32). Over one-quarter of IPs injected drugs, and injection by IPs was independently associated with RSS. Male partners may have power over FSW due to greater access to knowledge surrounding drug-related activities, including injection practices (2, 21). IPs who use drugs may also perpetrate violence in response to sex work disclosure, or threaten to report FSW to the police as a method of control (20, 49). Alternatively, the cathexis of social expectations of female subservience may influence some FSW-IDU to engage in RSS to build relationship intimacy, placing themselves at higher risk (53, 54). These dynamics may impede WWID to gain the skills necessary to self-inject - a potentially empowering tool to protect their own health. For WWID who are not confident in self-injection practices or face barriers to accessing this knowledge, being injected by others may be a harm reduction strategy to mitigate other IDU-related health risks such as abscesses that can form from missed veins. The role of IPV and IP substance use will be examined in a forthcoming paper from this cohort to understand and intervene on this critical issue.
Being injected by others (notably friends, acquaintances, family and IPs) was also common among FSW-IDU and elevated the odds of RSS. Previous studies show that WWID are more likely to share syringes with interpersonal connections including IPs and friends (27, 28). This may reflect higher levels of trust and a low perceived risk of HIV acquiring HIV from close relationships, as observed in one study (37). While further research is necessary to understand these practices, strategies to empower FSW-IDU to self-inject could be useful in mitigating the risk of HIV/HCV acquisition.
We also examined the relationship between syringe access and RSS. Our study occurred in a city with a large and established SSP, a key structural intervention against HIV/HCV transmission. The Baltimore city SSP is free and accessible six days a week at a variety of locations. The null association between RSS and recent SSP use may be due to lack of syringe coverage for all injections or a gap in education around RSS that the SSP could address. Of concern was the finding that 35% of FSW-IDU did not access the SSP, and that utilization of secondary sources (e.g., street needle sellers, IPs, and friends) held associations with lower SSP access and higher RSS. Multiple gendered barriers to SSP access exist for WWID including fear of GBV, losing children, childcare issues, and drug-related stigma (26, 27, 55). This supports the theory that both interpersonal and structural determinants have a role in shaping HIV/HCV risk. The vast majority of FSW-IDU engaging in RSS also shared cookers (91%) and cotton (72%), which are further risk factors for HCV acquisition. In light of our findings, we urge researchers to include this population and consider the role of gender dynamics when designing HIV/HCV research and interventions.
These data also emphasize that while the mainstay of HIV/HCV prevention among FSW-IDU remains the distribution of male condoms and traditional forms of SSP, the social realities faced by FSW-IDU warrant the design and delivery of interventions that target and empower them to help challenge existing gender-based structures. Evidence-based HIV interventions tailored for FSW-IDU are rare (56, 57). Given their risk profiles, future interventions could include improved access to HIV pre-exposure prophylaxis (PrEP), female condoms, and tailored women-led SSPs that are trauma-informed and consider the needs of FSW (e.g., destigmatizing, offer unconventional hours etc) (52, 58, 59). Training around self-injection practices, particularly among new initiates, or non-IDU, may be useful (23). Access to trauma-informed care, including mental health treatment will likely be required given the high rates of violence (15, 26). Concurrent to initiatives to prevent violence, and bolstering their internal and external resources to buffer the effects of violence will be important in reducing HIV/HCV risk. These interventions will also require consideration of the dually-criminalized status of FSW-IDU, which has implications for service engagement and retention (26). Increasing access to SSPs embedded within existing trauma-informed services that are tailored for women could be an effective method of service delivery.
Our findings should be interpreted in light of limitations. We did not ascertain specific dyadic interactions between FSW and their clients/IPs, rather we measured interactions occurring at the interpersonal-level (by partner type). The HIV serostatus and risk behaviors of injecting partners were not measured; it is challenging to ascertain relative risks that stem from these relationships. While we did not measure the number of injection partners or whether those providing syringes were also injection partners, it is theoretically plausible that this factor confounded or mediated the relationship between syringe access and RSS. However, our data suggest that despite overlap between these factors, they were distinct and individually provided important insights into RSS. Survey data has potential for social desirability bias. The study does not establish temporality though it is unlikely that RSS could lead to the contextual exposures (i.e., exposure to violence, assistance with injection, syringe access) modeled. The generalizability to other settings (e.g., where drug use patterns differ) is unknown.
These findings highlight the key role of interpersonal and structural risks in shaping health of FSW-IDU. Exposure to violence from clients and IPs is a pervasive issue and needs to be factored into future HIV/HCV intervention design among this population. Interventions targeting interpersonal and structural barriers to safety, sterile syringe access and risky injection practices will be necessary in reducing parenteral HIV/HCV risk among FSW-IDU.
Acknowledgments
Funding: This work was supported by the National Institute on Drug Abuse (R01DA038499–01) and the Johns Hopkins University Center for AIDS Research (1P30AI094189). The funders had no role in study design, data collection, or in analysis and interpretation of the results, and this paper does not necessarily reflect views or opinions of the funding agencies.
Footnotes
Conflict of interest: None.
Data statement: The research data is confidential.
References
- 1.Strathdee SA, Philbin MM, Semple SJ, Pu M, Orozovich P, Martinez G, et al. Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug Alcohol Depend 2008;92(1–3):132–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Platt L, Rhodes T, Lowndes CM, Madden P, Sarang A, Mikhailova L, et al. Impact of gender and sex work on sexual and injecting risk behaviors and their association with HIV positivity among injecting drug users in an HIV epidemic in Togliatti City, Russian Federation. Sex Transm Dis 2005;32(10):605–12. [DOI] [PubMed] [Google Scholar]
- 3.Spittal PM, Bruneau J, Craib KJ, Miller C, Lamothe F, Weber AE, et al. Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care 2003;15(2):187–95. [DOI] [PubMed] [Google Scholar]
- 4.Astemborski J, Vlahov D, Warren D, Solomon L, Nelson KE. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. Am J Public Health 1994;84(3):382–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Baral S, Beyrer C, Muessig K, Poteat T, Wirtz AL, Decker MR, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2012;12(7):538–49. [DOI] [PubMed] [Google Scholar]
- 6.Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health 2017;5(12):e1192–e207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Platt L, Jolley E, Rhodes T, Hope V, Latypov A, Reynolds L, et al. Factors mediating HIV risk among female sex workers in Europe: a systematic review and ecological analysis. BMJ Open 2013;3(7). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health 2001;91(1):42–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA 2002;288(2):199–206. [DOI] [PubMed] [Google Scholar]
- 10.Hagan H, Des Jarlais DC, Stern R, Lelutiu-Weinberger C, Scheinmann R, Strauss S, et al. HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. Int J Drug Policy 2007;18(5):341–51. [DOI] [PubMed] [Google Scholar]
- 11.Iversen J, Wand H, Gonnermann A, Maher L, collaboration of Australian N, Syringe P. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998–2008. Int J Drug Policy 2010;21(6):471–6. [DOI] [PubMed] [Google Scholar]
- 12.Pouget ER, Deren S, Fuller CM, Blaney S, McMahon JM, Kang SY, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr 2005;39(4):471–7. [DOI] [PubMed] [Google Scholar]
- 13.Lorvick J, Martinez A, Gee L, Kral AH. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health 2006;83(3):497–505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med 2005;61(5):1026–44. [DOI] [PubMed] [Google Scholar]
- 15.Auerbach JD, Smith LR. Theoretical Foundations of Research Focused on HIV Prevention Among Substance-Involved Women: A Review of Observational and Intervention Studies. J Acquir Immune Defic Syndr 2015;69 Suppl 2:S146–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Shannon K, Strathdee SA, Goldenberg SM, Duff P, Mwangi P, Rusakova M, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet 2015;385(9962):55–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.El-Bassel N, Wechsberg WM, Shaw SA. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIV AIDS 2012;7(4):326–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Connell RW, Pearse R. Gender: In world perspective Malden, MA: Polity Press.; 2014. [Google Scholar]
- 19.Connell RW. Gender and power: Society, the person and sexual politics: Stanford University Press; 1st edition; 1987. [Google Scholar]
- 20.Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med 2008;66(4):911–21. [DOI] [PubMed] [Google Scholar]
- 21.Maher L, Curtis R. Women on the edge of crime: Crack cocaine and the changing contexts of street-level sex work in New York City. Crime, Law and Social Change 1992;18(3):221–58. [Google Scholar]
- 22.Kral AH, Bluthenthal RN, Booth RE, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health 1998;88(1):108–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Novelli LA, Sherman SG, Havens JR, Strathdee SA, Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend 2005;77(3):303–9. [DOI] [PubMed] [Google Scholar]
- 24.Goldenberg SM, Rangel G, Vera A, Patterson TL, Abramovitz D, Silverman JG, et al. Exploring the impact of underage sex work among female sex workers in two Mexico-US border cities. AIDS Behav 2012;16(4):969–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Beletsky L, Lozada R, Gaines T, Abramovitz D, Staines H, Vera A, et al. Syringe confiscation as an HIV risk factor: the public health implications of arbitrary policing in Tijuana and Ciudad Juarez, Mexico. J Urban Health 2013;90(2):284–98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Blankenship KM, Reinhard E, Sherman SG, El-Bassel N. Structural Interventions for HIV Prevention Among Women Who Use Drugs: A Global Perspective. J Acquir Immune Defic Syndr 2015;69 Suppl 2:S140–5. [DOI] [PubMed] [Google Scholar]
- 27.Latkin CA, Mandell W, Knowlton AR, Doherty MC, Vlahov D, Suh T, et al. Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS education and prevention: official publication of the International Society for AIDS Education 1998;10(3):257–63. [PubMed] [Google Scholar]
- 28.Barnard MA. Needle sharing in context: patterns of sharing among men and women injectors and HIV risks. Addiction 1993;88(6):805–12. [DOI] [PubMed] [Google Scholar]
- 29.Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse 2001;36(14):2113–36. [DOI] [PubMed] [Google Scholar]
- 30.Fitzgerald T, Lundgren L, Chassler D. Factors associated with HIV/AIDS high-risk behaviours among female injection drug users. AIDS Care 2007;19(1):67–74. [DOI] [PubMed] [Google Scholar]
- 31.Wagner KD, Hudson SM, Latka MH, Strathdee SA, Thiede H, Mackesy-Amiti ME, et al. The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav 2009;13(2):217–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PG, Rekart M, et al. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver, Canada. Addiction 1997;92(10):1339–47. [PubMed] [Google Scholar]
- 33.Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse 2006;41(6–7):777–813. [DOI] [PubMed] [Google Scholar]
- 34.Des Jarlais DC. Structural interventions to reduce HIV transmission among injecting drug users. AIDS 2000;14 Suppl 1:S41–6. [DOI] [PubMed] [Google Scholar]
- 35.Nerlander LM, Hess KL, Rose CE, Sionean C, Thorson A, Broz D, et al. Exchange Sex and HIV Infection Among Women Who Inject Drugs-20 US Cities, 2009. J Acquir Immune Defic Syndr 2017;75 Suppl 3:S333–s40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wirtz AL, Peryshkina A, Mogilniy V, Beyrer C, Decker MR. Current and recent drug use intensifies sexual and structural HIV risk outcomes among female sex workers in the Russian Federation. Int J Drug Policy 2015;26(8):755–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Gu J, Lau JT, Chen H, Tsui H, Ling W. Prevalence and factors related to syringe sharing behaviours among female injecting drug users who are also sex workers in China. Int J Drug Policy 2011;22(1):26–33. [DOI] [PubMed] [Google Scholar]
- 38.Baral S, Todd CS, Aumakhan B, Lloyd J, Delegchoimbol A, Sabin K. HIV among female sex workers in the Central Asian Republics, Afghanistan, and Mongolia: contexts and convergence with drug use. Drug Alcohol Depend 2013;132 Suppl 1:S13–6. [DOI] [PubMed] [Google Scholar]
- 39.Strathdee SA, Lozada R, Martinez G, Vera A, Rusch M, Nguyen L, et al. Social and structural factors associated with HIV infection among female sex workers who inject drugs in the Mexico-US border region. PLoS One 2011;6(4):e19048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Sherman SG, Park JN, Galai N, Allen ST, Huettner SS, Silberzahn BE, Decker MR, Poteat TC, Footer KHA. Drivers of HIV infection among cisgender and transgender female sex worker populations in Baltimore city: Results from the SAPPHIRE study. J Acquir Immune Defic Syndr 2019. Jan 8. [DOI] [PubMed]
- 41.Allen ST, Footer KHA, Galai N, Park JN, Silberzahn B, Sherman SG. Implementing Targeted Sampling: Lessons Learned from Recruiting Female Sex Workers in Baltimore, MD. J Urban Health 2018. Jul 31. [DOI] [PMC free article] [PubMed]
- 42.Footer KHA, Park JN, Allen ST, Decker MR, Silberzahn BE, Huettner S, Galai N, Sherman SG. Police-Related Correlates of Client-Perpetrated Violence Among Female Sex Workers in Baltimore City, Maryland. Am J Public Health 2019. Feb;109(2):289–295 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Park JN, Weir BW, Allen ST, Chaulk P, Sherman SG. Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduct J 2018;15(1):34. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Brantley ML, Kerrigan D, German D, Lim S, Sherman SG. Identifying Patterns of Social and Economic Hardship Among Structurally Vulnerable Women: A Latent Class Analysis of HIV/STI Risk. AIDS Behav 2017;21(10):3047–56. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zhang C, Li X, Stanton B, Hong Y, Chen Y, Shan Q, et al. Alcohol use and client-perpetrated sexual violence against female sex workers in China. Psychol Health Med 2013;18(3):330–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Chersich MF, Luchters SM, Malonza IM, Mwarogo P, King’ola N, Temmerman M. Heavy episodic drinking among Kenyan female sex workers is associated with unsafe sex, sexual violence and sexually transmitted infections. Int J STD AIDS 2007;18(11):764–9. [DOI] [PubMed] [Google Scholar]
- 47.Shannon K, Strathdee SA, Shoveller J, Rusch M, Kerr T, Tyndall MW. Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy. Am J Public Health 2009;99(4):659–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Ulibarri MD, Strathdee SA, Ulloa EC, Lozada R, Fraga MA, Magis-Rodriguez C, et al. Injection drug use as a mediator between client-perpetrated abuse and HIV status among female sex workers in two Mexico-US border cities. AIDS Behav 2011;15(1):179–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Decker MR, Pearson E, Illangasekare SL, Clark E, Sherman SG. Violence against women in sex work and HIV risk implications differ qualitatively by perpetrator. BMC Public Health 2013;13:876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Vanwesenbeeck I Another decade of social scientific work on sex work: a review of research 1990–2000. Annu Rev Sex Res 2001;12:242–89. [PubMed] [Google Scholar]
- 51.Decker MR, Tomko C, Wingo E, Sawyer A, Peitzmeier S, Glass N, et al. A brief, trauma-informed intervention increases safety behavior and reduces HIV risk for drug-involved women who trade sex. BMC Public Health 2017;18(1):75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Decker MR, Crago AL, Chu SK, Sherman SG, Seshu MS, Buthelezi K, et al. Human rights violations against sex workers: burden and effect on HIV. Lancet 2015;385(9963):186–99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.MacRae R, Aalto E. Gendered power dynamics and HIV risk in drug-using sexual relationships. AIDS Care 2000;12(4):505–15. [DOI] [PubMed] [Google Scholar]
- 54.Gyarmathy VA, Li N, Tobin KE, Hoffman IF, Sokolov N, Levchenko J, et al. Injecting equipment sharing in Russian drug injecting dyads. AIDS Behav 2010;14(1):141–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Rolon ML, Syvertsen JL, Robertson AM, Rangel MG, Martinez G, Ulibarri MD, et al. The influence of having children on HIV-related risk behaviors of female sex workers and their intimate male partners in two Mexico-US border cities. J Trop Pediatr 2013;59(3):214–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Rusakova M, Rakhmetova A, Strathdee SA. Why are sex workers who use substances at risk for HIV? Lancet 2015;385(9964):211–2. [DOI] [PubMed] [Google Scholar]
- 57.Strathdee SA, Abramovitz D, Lozada R, Martinez G, Rangel MG, Vera A, et al. Reductions in HIV/STI incidence and sharing of injection equipment among female sex workers who inject drugs: results from a randomized controlled trial. PLoS One 2013;8(6):e65812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Raifman J, Sherman SG. US Guidelines That Empower Women to Prevent HIV With Preexposure Prophylaxis. Sex Transm Dis 2018;45(6):e38–e9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Beyrer C, Crago AL, Bekker LG, Butler J, Shannon K, Kerrigan D, et al. An action agenda for HIV and sex workers. Lancet 2015;385(9964):287–301. [DOI] [PMC free article] [PubMed] [Google Scholar]